Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Bile Duct Cancer in New Zealand
Total 0 results
Nothing found
Sponsors and Collaborators
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Eurofins Genoma
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Hospital ASEPEYO Sant Cugat
Hospital Durand, Argentina
ASST Cremona, Cremona
Korean Society of Spine Surgery
Apollo Neuroscience, Inc.
Aptis Medical
Agency for Science, Technology and Research
Mª Victoria Maestre Sanchez
Neurophth Therapeutics Inc
RMIT University, Melbourne, Australia
Alma Lasers Inc.
Kupfer, David J., M.D.
Nacuity Pharmaceuticals, Inc.
Everett Meyer
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
GFI
iCAD
View Full List
Medical Conditions
Tobacco, Alcohol, Prescription Drug, and Illicit Substance Use
Optimys Femoral Stem
Surgical Patient
Age-related Hearing Loss
Sporadic
LOW OVARIAN RESPONSE
Accuracy and Precision of Noninvasive Measurement
Extraarticular Fracture
Hospital Acquired Pressure Ulcer
Decay
Dislocation, Shoulder
Renal Function Disorder
Social Anxiety
Post Covid-19 Condition
STEMI - ST-segment Elevation Myocardial Infarction
Anatomic Stage 2A Breast Cancer AJCC v8
PD-1 Refractory Advanced Melanoma
Artificial Pancreas
Anaplastic Large-cell Lymphoma
Neck Mass
View Full List
Drug Interventions
Standard of care (SOC) for COVID-19
GLPG1837 multiple ascending doses
Intravenous deferiprone
Anticholinergic
OnabotulinumtoxinA
RDX227675
Letrozole
PD-1/PD-L1 inhibitor
TPN-101
Intravenous Formulation of PD-0332991
Midazolam
Fospropofol disodium, propofol
MLN2480
Olopatadine
Oxycodone/acetaminophen 5/325 mg
Capecitabine and IMRT (if randomized to this arm)
THC
Capecitabine/cisplatin
Camptosar
Desvenlafaxine
View Full List
CROs by country
Contract Research Organizations in Benin
Contract Research Organizations in Brazil
Contract Research Organizations in Congo
Contract Research Organizations in Costa Rica
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Gambia
Contract Research Organizations in Ghana
Contract Research Organizations in Hong Kong
Contract Research Organizations in Italy
Contract Research Organizations in Mexico
Contract Research Organizations in South Africa
Contract Research Organizations in Sri Lanka
Contract Research Organizations in Uruguay
CRO list by country
CROs in Cameroon
SGS
All CROs in Cameroon
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe